Concepts (71)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nanostructures | 2 | 2019 | 112 | 0.740 |
Why?
|
| Pharmaceutical Preparations | 1 | 2021 | 101 | 0.700 |
Why?
|
| Silicon Dioxide | 2 | 2020 | 61 | 0.670 |
Why?
|
| Anti-Infective Agents | 1 | 2021 | 166 | 0.660 |
Why?
|
| Hepatic Stellate Cells | 1 | 2018 | 53 | 0.610 |
Why?
|
| Titanium | 1 | 2018 | 118 | 0.580 |
Why?
|
| Basigin | 1 | 2017 | 53 | 0.570 |
Why?
|
| Liver Cirrhosis | 1 | 2018 | 301 | 0.500 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2017 | 163 | 0.480 |
Why?
|
| Biomarkers, Tumor | 1 | 2017 | 508 | 0.440 |
Why?
|
| Liver Neoplasms | 1 | 2017 | 334 | 0.430 |
Why?
|
| Nanoparticles | 3 | 2021 | 254 | 0.210 |
Why?
|
| Alpinia | 1 | 2021 | 1 | 0.200 |
Why?
|
| Manganese Compounds | 1 | 2021 | 8 | 0.200 |
Why?
|
| Lignans | 1 | 2021 | 10 | 0.200 |
Why?
|
| Iron | 2 | 2021 | 197 | 0.190 |
Why?
|
| Hydrogen Peroxide | 1 | 2021 | 168 | 0.190 |
Why?
|
| Photosensitizing Agents | 1 | 2020 | 32 | 0.180 |
Why?
|
| Surface-Active Agents | 1 | 2021 | 57 | 0.180 |
Why?
|
| Doxycycline | 1 | 2020 | 49 | 0.180 |
Why?
|
| Prodrugs | 1 | 2020 | 54 | 0.180 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2020 | 82 | 0.180 |
Why?
|
| Staphylococcus aureus | 1 | 2021 | 175 | 0.170 |
Why?
|
| Neoplasms | 2 | 2021 | 1667 | 0.170 |
Why?
|
| Doxorubicin | 1 | 2020 | 231 | 0.160 |
Why?
|
| Escherichia coli | 1 | 2021 | 368 | 0.160 |
Why?
|
| Tumor Microenvironment | 1 | 2019 | 213 | 0.150 |
Why?
|
| Reactive Oxygen Species | 1 | 2020 | 499 | 0.150 |
Why?
|
| Peptides | 1 | 2021 | 455 | 0.150 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2018 | 135 | 0.150 |
Why?
|
| Actins | 1 | 2018 | 249 | 0.140 |
Why?
|
| Disease-Free Survival | 1 | 2017 | 349 | 0.130 |
Why?
|
| Lymphatic Metastasis | 1 | 2017 | 274 | 0.130 |
Why?
|
| Gene Expression | 1 | 2018 | 770 | 0.130 |
Why?
|
| Models, Biological | 1 | 2019 | 981 | 0.130 |
Why?
|
| Collagen | 1 | 2018 | 636 | 0.130 |
Why?
|
| Cell Line | 1 | 2018 | 1752 | 0.120 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 756 | 0.110 |
Why?
|
| Oxides | 1 | 2012 | 47 | 0.100 |
Why?
|
| Graphite | 1 | 2012 | 46 | 0.100 |
Why?
|
| Prognosis | 1 | 2017 | 2093 | 0.100 |
Why?
|
| Nanotubes, Carbon | 1 | 2010 | 73 | 0.080 |
Why?
|
| Mice | 3 | 2021 | 8474 | 0.060 |
Why?
|
| Humans | 4 | 2020 | 68618 | 0.060 |
Why?
|
| Rhizome | 1 | 2021 | 3 | 0.050 |
Why?
|
| Diarylheptanoids | 1 | 2021 | 3 | 0.050 |
Why?
|
| Melanoma, Experimental | 1 | 2021 | 95 | 0.050 |
Why?
|
| Porosity | 1 | 2020 | 63 | 0.050 |
Why?
|
| Plant Extracts | 1 | 2021 | 122 | 0.040 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2020 | 111 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2021 | 397 | 0.040 |
Why?
|
| Photochemotherapy | 1 | 2020 | 59 | 0.040 |
Why?
|
| Particle Size | 1 | 2020 | 201 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2021 | 234 | 0.040 |
Why?
|
| Surface Properties | 1 | 2020 | 363 | 0.040 |
Why?
|
| Animals | 3 | 2021 | 20881 | 0.040 |
Why?
|
| Cell Cycle | 1 | 2020 | 312 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2020 | 852 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2021 | 1851 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2020 | 718 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2020 | 1174 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 1070 | 0.030 |
Why?
|
| Apoptosis | 1 | 2020 | 1641 | 0.030 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2012 | 38 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2012 | 237 | 0.030 |
Why?
|
| Endocytosis | 1 | 2012 | 113 | 0.030 |
Why?
|
| Gold | 1 | 2012 | 76 | 0.030 |
Why?
|
| Metal Nanoparticles | 1 | 2012 | 88 | 0.020 |
Why?
|
| Molybdenum | 1 | 2010 | 7 | 0.020 |
Why?
|
| Catalysis | 1 | 2010 | 123 | 0.020 |
Why?
|
| Alloys | 1 | 2010 | 66 | 0.020 |
Why?
|